Companies » Company Overview » Ranbaxy Laboratories Ltd.
 
 
  • BSE: 500359
  • NSE: RANBAXY
  • ISIN Code: INE015A01028
  • Sector: Health care
bse
15:48 PM,27th Jan 2015
706.90
0.65 (0.09%)
Open 708.00
Day High 711.70
Day Low 694.00
Previous Close 706.25
Volume 68206
52-Week high 714.20
52-Week low 306.05
P/E 129.94
Mkt Cap.(Rs cr) 30090
NSE
15:55 PM,27th Jan 2015

707.95
1.35 (0.19%)
Bse
15:48 PM,27th Jan 2015

706.90
0.65 (0.09%)
nse
15:55 PM,27th Jan 2015
707.95
1.35 (0.19%)
Open 711.15
Day High 713.50
Day Low 694.00
Previous Close 706.60
Volume 656889
52-Week high 714.65
52-Week low 305.20
P/E 129.94
Mkt Cap.(Rs cr) 30090

Ranbaxy Laboratories Ltd. (RANBAXY) - Company Information

Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The company has a global footprint in 46 countries, world-class manufacturing facilities in 8 countries and serves customers in over 125 count... [More]

Key Fundamentals
Market Cap (Rs cr) 30,090
EPS - TTM (Rs)

[*C]

5.44
P/E Ratio (x)

[*C]

129.94
Face Value (Rs) 5
Latest Dividend (%) 40.00
Latest Dividend Date 28 Apr 2011
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*C]

77.51
P/B Ratio (x)

[*C]

9.12
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
694.00
711.70
Week Low/High
627.40
714.00
Month Low/High
604.00
714.00
YEAR Low/High
306.05
714.00
All TIME Low/High
4.75
714.00
Peer Group
Company Last Change(%)
Cadila Health. 1652.20 0.42
Aurobindo Pharma 1175.60 -0.16
Torrent Pharma. 1186.25 3.77
Glenmark Pharma. 733.00 0.89
Piramal Enterp. 837.50 0.37
Wockhardt 1143.30 2.01
Alembic Pharma 481.35 0.93
Returns
Period Ranbaxy Labs. Sensex NIFTY
1 Week 9.11% 5.15% 4.66%
1 Month 15.31% 7.51% 7.78%
3 Month 18.26% 10.13% 11.18%
6 Month 26.10% 13.09% 14.30%
1 Year 69.46% 38.35% 40.42%
3 Year 52.23% 76.53% 76.58%
Period Ranbaxy Labs. Sensex NIFTY
1 Week 9.15% 5.15% 4.66%
1 Month 15.50% 7.51% 7.78%
3 Month 18.49% 10.13% 11.18%
6 Month 26.16% 13.09% 14.30%
1 Year 69.59% 38.35% 40.42%
3 Year 52.76% 76.53% 76.58%
Financial Results
Particulars (Rs cr) Sep 2014 Sep 2013 %Chg
Net Sales 3260.49 2801.64 16.38
Other Income 17.39 26.09 -33.35
Total Income 3277.88 2827.73 15.92
Total Expenses 2577.29 2974.2 -13.35
Operating Profit 700.59 -146.47 578.32
Net Profit 478.17 -448.32 206.66
Equity Capital 211.95 211.52 -
SHAREHOLDING PATTERN
As on Dec 2014
Research Reports
Date Broker Action Price Report
03/11 Angel Broking Neutral 634 PDF Icon
28/10 Motilal Oswal Buy 634 PDF Icon
28/10 Prabhudas Lilladhar Accumulate 634 PDF Icon
04/08 Angel Broking Neutral 565 PDF Icon
30/07 Prabhudas Lilladhar Accumulate 590 PDF Icon
Board of directors
Director : Takashi Shoda
Chairman : Tsutomu Une
Director : Rajesh V Shah
Company Secretary : S K Patawari
Managing Director & CEO : Arun Sawhney
Director : Anthony H Wild
Director : Akihiro Watanabe
Director : Kazunori Hirokawa
Director : Percy K Shroff
AUDITOR: BSR & Co LLP
IND NAME: Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME: MNC Associate
Registered office
Plot No 90, Sector 32,
Gurgaon,Haryana-122001
Ph: 91-0124-4135000
E-mail:
URL: http://www.ranbaxy.com

Quick Links

Quick Links for Ranbaxy Laboratories

Back to Top